The Estonian health technology enterprise Antegenes has signed a long-term strategic partnership agreement with Everything Genetic Ltd to introduce the genetic tests used for cancer prevention to the healthcare system of the United Kingdom. Together with the agreement, the Estonian enterprise received an investment of 500,000 euros.